A Cautious Yes

A new survey suggests that many Americans would consider taking part in a clinical trial, but that most of their doctors do not discuss medical research with them, writes Ed Silverman at Pharmalot.

Silverman notes that previously cited reasons for low participation rates in trials include wide access to medication and difficulties in finding participants who are not taking other medications that could influence the trial.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.